Cell Culture Media, Sera, and Reagents Market Size, Share, Trends, Growth, Consumption, Revenue, Company Analysis and Forecast 2021-2027

Published Date : Nov 2020 | No. of Pages : 200 Pages | Category : Healthcare

The global cell culture media, sera, and reagents market size surpassed at US$ 5.2 billion in 2020 and to reach US$ 8.4 billion by 2027 with a CAGR of 5.8% from 2021 to 2027.

Contract research and manufacturing, and focus on stem cell research would expand the scope of cell culture,growing demand for biopharmaceuticals and artificial organs, and trend towards serum-free, specialty and customized media solutions are projected to drive the global cell culture media, sera, and reagents market during the forecast period.

The global cell culture media, sera and reagents market is witnessing impressive growth due to the increase in demand for biopharmaceutical products. Since its introduction as an integral part of the life sciences industry, the cell culture market has witnessed significant growth in terms of scope as well as adoption by the end-users.

The double-digit growth in the biotechnology and biopharmaceutical industries is the major factor likely to boost the growth of the cell culture media, sera and reagents market in the near future.

Growing Demand for Biopharmaceuticals and Artificial Organs to Drive Market

  • The current USD 200 billion plus global biological drugs market comprises hormones, vaccines, monoclonal antibodies, therapeutic enzymes, blood factors, etc. The limited applicability of conventional pharmaceuticals in curing diseased or injured tissues has led to an increasing demand for the biologics mentioned above.
  • The incredible specificity of biopharmaceuticals has opened new avenues in health care such as personalized medicine, wherein various diseases or conditions can be treated using specific biomolecules depending upon the patient’s physiological, biological, and genetic makeup.
  • Limited competition from generics (called biosimilars) is also fueling market growth, as these drugs are developed using unique processes involving growth of live cell cultures under controlled environmental conditions.
  • Artificial organs are engineered biological substitutes used to replace the structure and restore the functions of an impaired or diseased organ. The market for these artificial organs is expected to grow at a double digit CAGR of 25% in the near future, indicating an increasing demand and strong growth potential in the cell culture market.
  • Cell-based applications of regenerative medicine include development of artificial organs and tissue and bone grafts to restore lost body functions. Development of specialty growth media and culture techniques that ensure specificity and availability of high end technology for scaling up cultures are important factors that would drive the market growth in these segments.

Classical Media Segment to Dominate Market

  • Based on media type, the global cell culture media, sera, and reagents market has been divided into chemically-defined, classical, Lysogeny Broth (LB), protein-free, serum-free, and specialty. The classical media segment accounted for majority share of the global cell culture media, sera, and reagents market in 2018.
  • A classical cell culture media contains a mixture of specific nutrients such as acids, salts, vitamins, and sugar mixed in a buffered physiological saline solution. The constituents of basal media are defined on the basis of the type of culture system being used and the nature of cells to be cultured.

Fetal Bovine to be Highly Lucrative Segment

  • In terms of product, the global cell culture media, sera, and reagents market has been classified into fetal bovine, newborn calf and adult bovine, and others.
  • Serum is commonly used as a supplement in cell culture media. Sera provides wide range of macromolecules, trace elements, carrier proteins, spreading factors, hormones, low molecular weight nutrients and other growth factors. Fetal bovine serum (FBS) is the most common sera type used in cell culture medium.
  • Fetal bovine serum (FBS) is the remnant blood fraction drawn from bovine fetus. FBS is a widely used serum supplement for in vitro cell culture of eukaryotic cells.

North America to Dominate Global Market

  • In terms of region, the global cell culture media, sera, and reagents market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global cell culture media, sera, and reagents market in 2018, followed by Europe.
  • It is driven by a large patient pool suffering from malignant diseases such as leukemia and lymphoma, bacterial and viral infections, and metabolic diseases as well as research and development projects for drug discovery that are currently underway.
  • The emerging economies of Asia Pacific, the Middle East, Latin America, and Africa are anticipated to be major contributors to the growth of cell culture market during the forecast period.

Competitive Landscape

  • The global cell culture media, sera, and reagents market is fragmented in terms of number of players. Key players in the global market include Sigma-Aldrich Corporation, BD Biosciences, EMD Millipore, Thermo Fisher Scientific, Inc., GE Healthcare, Lonza Biosciences, VWR International, and Corning incorporated, Eppendorf AG., HiMedia Laboratories, WuXi AppTec, Sumitomo Bakelite Co., Ltd., PAA Laboratories, PromoCell GmbH, and Takara Bio, Inc., among others.

Market Segmentation

By Media Type

    • Chemically-defined
    • Classical
    • LB
    • Protein-free
    • Serum-free
    • Specialty

By Product

    • Fetal Bovine
    • Newborn calf and adult bovine
    • Others

By Reagents

    • Albumin
    • Amino acids
    • Attachment factors
    • Growth Factors & Cytokines
    • Protease Inhibitors
    • Others

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific        
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Scope of Report

VRR’s report on the global cell culture media, sera and reagents market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global cell culture media, sera and reagents market for the period 2017–2027, considering 2020 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global cell culture media, sera and reagents market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global cell culture media, sera and reagents market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a Protein-free of top-down and bottom-up approaches to study various phenomenon in the global Cell Culture Media, Sera and Reagents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global cell culture media, sera and reagents market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global cell culture media, sera and reagents market.

The report delves into the competitive landscape of the global cell culture media, sera and reagents market. Key players operating in the global cell culture media, sera and reagents market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global cell culture media, sera and reagents market that have been profiled in this report.

Key Questions Answered in Global Cell Culture Media, Sera and Reagents Market Report

  • What is the scope of growth of product companies in the global Cell Culture Media, Sera and Reagents market?
  • What will be the Y-o-Y growth of the global Cell Culture Media, Sera and Reagents market between 2021 and 2027?
  • What is the influence of changing trends in technologies on the global Cell Culture Media, Sera and Reagents market?
  • Will North America continue to be the most profitable market for Cell Culture Media, Sera and Reagents providers?
  • Which factors are anticipated to hamper the growth of the global Cell Culture Media, Sera and Reagents market during the forecast period?
  • Which are the leading companies in the global Cell Culture Media, Sera and Reagents market?

Research Methodology

A unique research methodology has been utilized by VRR to conduct comprehensive research on the growth of the global Cell Culture Media, Sera and Reagents market and arrive at conclusions on its growth prospects. This research methodology is a Protein-free of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global Cell Culture Media, Sera and Reagents market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of VRR’s study on the Cell Culture Media, Sera and Reagents market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the Cell Culture Media, Sera and Reagents market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global Cell Culture Media, Sera and Reagents market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching VRR’s estimates on future prospects of the global Cell Culture Media, Sera and Reagents market more reliably and accurately.

Table of Contents

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecasts, 2017–2027

5. Key Insights

    5.1. Product Overview

    5.2. Key Industry Developments

    5.3. Emerging Trends in Cell Culture Media, Sera and Reagents Market

6. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecasts, By Media Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value  Forecast By Media Type, 2017–2027

        6.3.1. Chemically-defined

        6.3.2. Classical

        6.3.3. Lysogeny Broth (LB)

        6.3.4. Protein-free

        6.3.5. Serum-free

        6.3.6. Specialty

    6.4. Market Attractiveness By Media Type

7. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecasts, By Product

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value  Forecast By Product, 2017–2027

        7.3.1. Fetal Bovine

        7.3.2. Newborn calf and adult bovine

        7.3.3. Others

        7.3.4. HPV

        7.3.5. Meningococcal

        7.3.6. Rotavirus

        7.3.7. Measles and Rubella

        7.3.8. Typhoid

        7.3.9. Protein-free

        7.3.10. Specialty

    7.4. Market Attractiveness By Product

8. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecasts, By Reagents

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value  Forecast By Reagents, 2017–2027

        8.3.1. Albumin

            8.3.1.1. Human Serum Albumin

            8.3.1.2. Bovine Serum Albumin

            8.3.1.3. Recombinant Serum Albumin

        8.3.2. Amino acids

        8.3.3. Attachment factors

        8.3.4. Growth Factors & Cytokines

            8.3.4.1. Insulin-Like Growth Factors

            8.3.4.2. Interleukins and Interferons

            8.3.4.3. Tumor necrosis factors

            8.3.4.4. Others

        8.3.5. Protease Inhibitors

        8.3.6. Others

            8.3.6.1. Recombinant Trypsin

            8.3.6.2. Porcine Trypsin

            8.3.6.3. Thrombin

            8.3.6.4. Miscellaneous Reagents

    8.4. Market Attractiveness By Reagents

9. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecasts, By Region

    9.1. Key Findings

    9.2. Market Value  Forecast By Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness By Region

10. North America Cell Culture Media, Sera and Reagents Market Analysis and Forecast

    10.1. Introduction

    10.2. Market Value  Forecast By Media Type, 2017–2027

        10.2.1. Chemically-defined

        10.2.2. Classical

        10.2.3. Lysogeny Broth (LB)

        10.2.4. Protein-free

        10.2.5. Serum-free

        10.2.6. Specialty

    10.3. Market Value  Forecast By Product, 2017–2027

        10.3.1. Fetal Bovine

        10.3.2. Newborn calf and adult bovine

        10.3.3. Others

    10.4. Market Value  Forecast By Reagents, 2017–2027

        10.4.1. Albumin

            10.4.1.1. Human Serum Albumin

            10.4.1.2. Bovine Serum Albumin

            10.4.1.3. Recombinant Serum Albumin

        10.4.2. Amino acids

        10.4.3. Attachment factors

        10.4.4. Growth Factors & Cytokines

            10.4.4.1. Insulin-Like Growth Factors

            10.4.4.2. Interleukins and Interferons

            10.4.4.3. Tumor necrosis factors

            10.4.4.4. Others

        10.4.5. Protease Inhibitors

        10.4.6. Others

            10.4.6.1. Recombinant Trypsin

            10.4.6.2. Porcine Trypsin

            10.4.6.3. Thrombin

            10.4.6.4. Miscellaneous Reagents

    10.5. Market Value  Forecast By Country, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Media Type

        10.6.2. By Product

        10.6.3. By Reagents

        10.6.4. By Country

11. Europe Cell Culture Media, Sera and Reagents Market Analysis and Forecast

    11.1. Introduction

    11.2. Market Value  Forecast By Media Type, 2017–2027

        11.2.1. Chemically-defined

        11.2.2. Classical

        11.2.3. Lysogeny Broth (LB)

        11.2.4. Protein-free

        11.2.5. Serum-free

        11.2.6. Specialty

    11.3. Market Value  Forecast By Product, 2017–2027

        11.3.1. Fetal Bovine

        11.3.2. Newborn calf and adult bovine

        11.3.3. Others

    11.4. Market Value  Forecast By Reagents, 2017–2027

        11.4.1. Albumin

            11.4.1.1. Human Serum Albumin

            11.4.1.2. Bovine Serum Albumin

            11.4.1.3. Recombinant Serum Albumin

        11.4.2. Amino acids

        11.4.3. Attachment factors

        11.4.4. Growth Factors & Cytokines

            11.4.4.1. Insulin-Like Growth Factors

            11.4.4.2. Interleukins and Interferons

            11.4.4.3. Tumor necrosis factors

            11.4.4.4. Others

        11.4.5. Protease Inhibitors

        11.4.6. Others

            11.4.6.1. Recombinant Trypsin

            11.4.6.2. Porcine Trypsin

            11.4.6.3. Thrombin

            11.4.6.4. Miscellaneous Reagents

    11.5. Market Value  Forecast By Country, 2017–2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Media Type

        11.6.2. By Product

        11.6.3. By Reagents

        11.6.4. By Country

12. Asia Pacific Cell Culture Media, Sera and Reagents Market Analysis and Forecast

    12.1. Introduction

    12.2. Market Value  Forecast By Media Type, 2017–2027

        12.2.1. Chemically-defined

        12.2.2. Classical

        12.2.3. Lysogeny Broth (LB)

        12.2.4. Protein-free

        12.2.5. Serum-free

        12.2.6. Specialty

    12.3. Market Value  Forecast By Product, 2017–2027

        12.3.1. Fetal Bovine

        12.3.2. Newborn calf and adult bovine

        12.3.3. Others

    12.4. Market Value  Forecast By Reagents, 2017–2027

        12.4.1. Albumin

            12.4.1.1. Human Serum Albumin

            12.4.1.2. Bovine Serum Albumin

            12.4.1.3. Recombinant Serum Albumin

        12.4.2. Amino acids

        12.4.3. Attachment factors

        12.4.4. Growth Factors & Cytokines

            12.4.4.1. Insulin-Like Growth Factors

            12.4.4.2. Interleukins and Interferons

            12.4.4.3. Tumor necrosis factors

            12.4.4.4. Others

        12.4.5. Protease Inhibitors

        12.4.6. Others

            12.4.6.1. Recombinant Trypsin

            12.4.6.2. Porcine Trypsin

            12.4.6.3. Thrombin

            12.4.6.4. Miscellaneous Reagents

    12.5. Market Value  Forecast By Country, 2017–2027

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Media Type

        12.6.2. By Product

        12.6.3. By Reagents

        12.6.4. By Country

13. Latin America Cell Culture Media, Sera and Reagents Market Analysis and Forecast

    13.1. Introduction

    13.2. Market Value  Forecast By Media Type, 2017–2027

        13.2.1. Chemically-defined

        13.2.2. Classical

        13.2.3. Lysogeny Broth (LB)

        13.2.4. Protein-free

        13.2.5. Serum-free

        13.2.6. Specialty

    13.3. Market Value  Forecast By Product, 2017–2027

        13.3.1. Fetal Bovine

        13.3.2. Newborn calf and adult bovine

        13.3.3. Others

    13.4. Market Value  Forecast By Reagents, 2017–2027

        13.4.1. Albumin

            13.4.1.1. Human Serum Albumin

            13.4.1.2. Bovine Serum Albumin

            13.4.1.3. Recombinant Serum Albumin

        13.4.2. Amino acids

        13.4.3. Attachment factors

        13.4.4. Growth Factors & Cytokines

            13.4.4.1. Insulin-Like Growth Factors

            13.4.4.2. Interleukins and Interferons

            13.4.4.3. Tumor necrosis factors

            13.4.4.4. Others

        13.4.5. Protease Inhibitors

        13.4.6. Others

            13.4.6.1. Recombinant Trypsin

            13.4.6.2. Porcine Trypsin

            13.4.6.3. Thrombin

            13.4.6.4. Miscellaneous Reagents

    13.5. Market Value  Forecast By Country, 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Media Type

        13.6.2. By Product

        13.6.3. By Reagents

        13.6.4. By Country

14. Middle East & Africa Cell Culture Media, Sera and Reagents Market Analysis and Forecast

    14.1. Introduction

    14.2. Market Value  Forecast By Media Type, 2017–2027

        14.2.1. Chemically-defined

        14.2.2. Classical

        14.2.3. Lysogeny Broth (LB)

        14.2.4. Protein-free

        14.2.5. Serum-free

        14.2.6. Specialty

    14.3. Market Value  Forecast By Product, 2017–2027

        14.3.1. Fetal Bovine

        14.3.2. Newborn calf and adult bovine

        14.3.3. Others

    14.4. Market Value  Forecast By Reagents, 2017–2027

        14.4.1. Albumin

            14.4.1.1. Human Serum Albumin

            14.4.1.2. Bovine Serum Albumin

            14.4.1.3. Recombinant Serum Albumin

        14.4.2. Amino acids

        14.4.3. Attachment factors

        14.4.4. Growth Factors & Cytokines

            14.4.4.1. Insulin-Like Growth Factors

            14.4.4.2. Interleukins and Interferons

            14.4.4.3. Tumor necrosis factors

            14.4.4.4. Others

        14.4.5. Protease Inhibitors

        14.4.6. Others

            14.4.6.1. Recombinant Trypsin

            14.4.6.2. Porcine Trypsin

            14.4.6.3. Thrombin

            14.4.6.4. Miscellaneous Reagents

    14.5. Market Value  Forecast By Country, 2017–2027

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Media Type

        14.6.2. By Product

        14.6.3. By Reagents

        14.6.4. By Country

15. Competition Landscape

    15.1. Market Share Analysis By Company (2019)

    15.2. Company Profiles

        15.2.1. Becton, Dickinson and Company

            15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.1.2. Growth Strategies

            15.2.1.3. SWOT Analysis

        15.2.2. Corning Life Sciences B.V.

            15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.2.2. Growth Strategies

            15.2.2.3. SWOT Analysis

        15.2.3. EMD Millipore

            15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.3.2. Growth Strategies

            15.2.3.3. SWOT Analysis

        15.2.4. GE Healthcare

            15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.4.2. Growth Strategies

            15.2.4.3. SWOT Analysis

        15.2.5. Lonza Group Ltd

            15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.5.2. Growth Strategies

            15.2.5.3. SWOT Analysis

        15.2.6. PromoCell GmbH

            15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.6.2. Growth Strategies

            15.2.6.3. SWOT Analysis

        15.2.7. Thermo Fisher Scientific, Inc.

            15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.7.2. Growth Strategies

            15.2.7.3. SWOT Analysis

        15.2.8. Merck & Co, Inc.

            15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.8.2. Growth Strategies

            15.2.8.3. SWOT Analysis

        15.2.9. VWR International, LLC

            15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.9.2. Growth Strategies

            15.2.9.3. SWOT Analysis

        15.2.10. Wheaton Industries, Inc.

            15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.10.2. Growth Strategies

            15.2.10.3. SWOT Analysis


Featured Research Reports

  • Featured Research Reports

    Retinal Disorders Treatment Market (By Indication: Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema, and Others; By Therapeutic Class; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Dystrophic Epidermolysis Bullosa Treatment Market (By Treatment Type: Antibiotics, Corticosteroids, Opioid Analgesics, Anticonvulsant, Others; By Disease Type: DDEB and RDEB; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Bromelain Market (By Application: Food & Beverages, Healthcare & Pharmaceuticals, Cosmetics, and Other Industries; By Source: Stem and Fruit) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Chronic Idiopathic Constipation Treatment Market (By Drug Class: Serotonin-4 [5-Ht4] Receptor Agonist, Guanylate Cyclase-C Agonist, Laxatives, Stimulants, Others; By Route of Administration: Oral and Rectal; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Hemoglobin Feed Market (By Source: Bovine, Swine, Poultry, Shark, Synthetic, Others; By Application: Industrial and Commercial) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...